Cowen Survey: When Do You Believe The FDA Will Be Back To Pre-COVID Levels Of Functionality? 

While investors are focused on key pandemic-related approvals, sentiment regarding FDA efficiency has been low, with our own investor survey suggesting that the Agency will not return to pre-pandemic functionality until H2:23 (45% of responses), with nearly 1/4 of investor respondents indicating the Agency’s functionality has been changed forever.